GBV-C infection among patients with hepatitis C virus in the Islamic Republic of Iran: A preliminary report

Eastern Mediterranean Health Journal

Volumn 5, Issue 5, 1999, Pages 1030-1034

  Zali, M R ^a   Mayumi, M ^b   Raoufi, M ^c   Nowroozi, A ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c Iranian Academy of Medical Sciences   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD DONOR; DISEASE TRANSMISSION; EPIDEMIOLOGY; FLAVIVIRUS; GENETICS; HEPATITIS C; HUMAN; IRAN; LIVER DISEASE; POLYMERASE CHAIN REACTION; PREVALENCE; RENAL REPLACEMENT THERAPY; TRANSPLANTATION; VIROLOGY; VIRUS HEPATITIS;

BLOOD DONORS; FLAVIVIRIDAE; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HUMANS; IRAN; LIVER DISEASES; POLYMERASE CHAIN REACTION; PREVALENCE; RENAL DIALYSIS; SEROEPIDEMIOLOGIC STUDIES; TRANSPLANTATION;

EID: 0033186828     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Okamoto H et al. A second-generation method of genotyping hepatitis C virus by the polymerase chain reaction with sense and antisense primers deduced from the core gene. Journal of virology methods, 1996, 57:31-45.
2. Hadziyannis SJ et al. Frequency of viraemia with a new hepatitis virus (HGV) in patients with liver disease and in groups at high risk of exposure to blood and blood products. Journal of hepatology, 1995,23:78.
3. de Lamballerie X et al. Hepatitis GB virus C in patients on hemodialysis. New England journal of medicine, 1996, 334:1549.
4. Masuko K et al. Infection with GB virus C in patients on maintenance hemodialysis. New England journal of medicine, 1996, 334:1485-90.
5. Yoshiba M et al. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet, 1995, 346:1131-2.
6. Murthy BV et al. GB hepatitis agent in cadaver organ donors and their recipients. Transplantation, 1997, 63:346-51.
7. Alter HJ. The cloning and clinical implications of HGV and HGBV-C. New England journal of medicine, 1996, 334:1536-7.
8. Madejon A et al. GB virus C RNA in serum, liver and peripheral blood mononuclear cells from patients with chronic hepatitis B, C and D. Gastroenterology, 1997, 113:573-8.
9. Karayiannis P, Thomas H. Hepatitis G virus: identification and prevalence. British journal of hospital medicine, 1996, 56:238-40.
10. Kuroki T et al. Does GBV-C causes fulminant hepatitis in Japan? Lancet, 1996, 347:908.
11. Jarvis LM et al. Infection with hepatitis G virus among recipients of plasma products. Lancet, 1996, 348:1352-5.
12. Martinol M et al. Influence of hepatitis G virus infection on the severity of liver disease and response to interferon alpha in patients with chronic hepatitis C. Annals of internal medicine, 1997, 126:874-81.
13. Tanaka E et al. Effect of hepatitis G infection on chronic hepatitis. Annals of internal medicine, 1996, 125:740-3.
14. Aikawa T et al. Hepatitis G infection in drug abusers with chronic hepatitis C. New England journal of medicine, 1996, 334:195-6.
15. Feucht HH et al. Distribution of hepatitis G viremia and antibody response to recombinant proteins with special regard to risk factors in 709 patients. Hepatology, 1997, 26:491-4.
16. Alter HJ, Seef LB. Transfusion associated hepatitis. In: Zuckerman AJ, Thomas HC, eds. Viral hepatitis. London, Churchill Livingstone, 1993:467-98.
17. Simons JN et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proceedings of the National Academy of Sciences of the United States of America, 1995, 29:3401-5.
18. Alter HJ et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team. New England journal of medicine, 1997, 336:741-6.
19. Alter HJ et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. New England journal of medicine, 1997, 336:747-54.